Surgery versus SABR for resectable non-small-cell lung cancer.

作者信息

Zhang Lei, Tian Jingru, Wang Changli

机构信息

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Lung Cancer Center, Department of Thoracic Surgery, Tianjin, China.

Xiangya School of Medicine, Central South University, Changsha, China.

出版信息

Lancet Oncol. 2015 Aug;16(8):e371-2. doi: 10.1016/S1470-2045(15)00063-7.

DOI:10.1016/S1470-2045(15)00063-7

PMID:26248837

Abstract

摘要

相似文献

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e371-2. doi: 10.1016/S1470-2045(15)00063-7.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e370-1. doi: 10.1016/S1470-2045(15)00036-4.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e372-3. doi: 10.1016/S1470-2045(15)00123-0.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1.

Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.

Lancet Oncol. 2015 Aug;16(8):e374-5. doi: 10.1016/S1470-2045(15)00154-0.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e373-4. doi: 10.1016/S1470-2045(15)00145-X.

SABR vs surgery for NSCLC in the media.

Lancet Oncol. 2015 Sep;16(9):e422. doi: 10.1016/S1470-2045(15)00230-2.

SABR in early operable lung cancer: time for evidence.

Lancet Oncol. 2015 Jun;16(6):597-8. doi: 10.1016/S1470-2045(15)70225-1. Epub 2015 May 13.

Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.

Lancet Oncol. 2016 Feb;17(2):e41-e42. doi: 10.1016/S1470-2045(16)00026-7.

Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?

J Thorac Cardiovasc Surg. 2015 Sep;150(3):468-71. doi: 10.1016/j.jtcvs.2015.06.086. Epub 2015 Jul 14.

引用本文的文献

Salvage surgery after high-dose radiotherapy.

J Thorac Dis. 2017 Apr;9(Suppl 3):S193-S200. doi: 10.21037/jtd.2017.03.88.

Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.

Lung Cancer. 2017 Jan;103:6-10. doi: 10.1016/j.lungcan.2016.11.005. Epub 2016 Nov 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e371-2. doi: 10.1016/S1470-2045(15)00063-7.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e370-1. doi: 10.1016/S1470-2045(15)00036-4.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e372-3. doi: 10.1016/S1470-2045(15)00123-0.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1.

Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.

Lancet Oncol. 2015 Aug;16(8):e374-5. doi: 10.1016/S1470-2045(15)00154-0.

Surgery versus SABR for resectable non-small-cell lung cancer.

Lancet Oncol. 2015 Aug;16(8):e373-4. doi: 10.1016/S1470-2045(15)00145-X.

SABR vs surgery for NSCLC in the media.

Lancet Oncol. 2015 Sep;16(9):e422. doi: 10.1016/S1470-2045(15)00230-2.

SABR in early operable lung cancer: time for evidence.

Lancet Oncol. 2015 Jun;16(6):597-8. doi: 10.1016/S1470-2045(15)70225-1. Epub 2015 May 13.

Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.

Lancet Oncol. 2016 Feb;17(2):e41-e42. doi: 10.1016/S1470-2045(16)00026-7.

Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?

J Thorac Cardiovasc Surg. 2015 Sep;150(3):468-71. doi: 10.1016/j.jtcvs.2015.06.086. Epub 2015 Jul 14.

引用本文的文献

Salvage surgery after high-dose radiotherapy.

J Thorac Dis. 2017 Apr;9(Suppl 3):S193-S200. doi: 10.21037/jtd.2017.03.88.

Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.

Lung Cancer. 2017 Jan;103:6-10. doi: 10.1016/j.lungcan.2016.11.005. Epub 2016 Nov 9.